Skip to main content
. 2023 Jan 18;5(1):zcad002. doi: 10.1093/narcan/zcad002

Graphical Abstract.

Graphical Abstract

The level of 57 tumour-specific miRNAs reflects tumour burden and hsa-miR-34a-5p is a potential pharmacodynamic biomarker as its abundance in circulation is higher upon effective therapeutic targeting with idasanutlin.